Soiken Holdings (2385) Stock Overview

Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for pharmaceutical clinical research and epidemiology studies; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. The company was incorporated in 1994 and is headquartered in Toyonaka, Japan.

2385 Stock Information

Symbol

2385

Address

Senri Life Science CenterToyonaka, 560-0082Japan

Founded

Trading hours

Website

https://www.soiken.com

Country

🇯🇵 Japan

Phone Number

81 6 6871 8888

Soiken Holdings (2385) Price Chart

Soiken Holdings Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.8015513897866839	N/A
Market Cap	$20.97M	N/A
Shares Outstanding	26.16M	0.00%
Employees	98.00	N/A
Shareholder Equity	7.17B	4.74%

Valuation	2023	Change
P/E Ratio	0.05	N/A
P/S Ratio	0.40	N/A
P/B Ratio	0.00	N/A

Growth	2023	Change
Return on Equity	0.0004	N/A

Earnings	2023	Change
Revenue	$52.23M	N/A
Earnings	$2.95M	N/A
EPS	17.27	N/A
Earnings Yield	21.55	N/A
Gross Margin	0.4599	N/A
Operating Margin	0.0898	N/A
Net income margin	0.0564	N/A

Financial Strength	2023	Change
Total Assets	$53.26M	N/A
Cash on Hand	$38.43M	N/A
Debt to Equity	0.0010	-37.92%
Current Ratio	$7.60	50.58%